184 related articles for article (PubMed ID: 12586831)
1. Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.
Chen L; Estève E; Sabatier JM; Ronjat M; De Waard M; Allen PD; Pessah IN
J Biol Chem; 2003 May; 278(18):16095-106. PubMed ID: 12586831
[TBL] [Abstract][Full Text] [Related]
2. Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells.
Estève E; Smida-Rezgui S; Sarkozi S; Szegedi C; Regaya I; Chen L; Altafaj X; Rochat H; Allen P; Pessah IN; Marty I; Sabatier JM; Jona I; De Waard M; Ronjat M
J Biol Chem; 2003 Sep; 278(39):37822-31. PubMed ID: 12869557
[TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors.
Fajloun Z; Kharrat R; Chen L; Lecomte C; Di Luccio E; Bichet D; El Ayeb M; Rochat H; Allen PD; Pessah IN; De Waard M; Sabatier JM
FEBS Lett; 2000 Mar; 469(2-3):179-85. PubMed ID: 10713267
[TBL] [Abstract][Full Text] [Related]
4. Maurocalcine interacts with the cardiac ryanodine receptor without inducing channel modification.
Altafaj X; France J; Almassy J; Jona I; Rossi D; Sorrentino V; Mabrouk K; De Waard M; Ronjat M
Biochem J; 2007 Sep; 406(2):309-15. PubMed ID: 17537000
[TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive stimulation of type-1 ryanodine receptors by the scorpion toxin maurocalcine.
Ronjat M; Finkelstein JP; Llanos P; Montecinos L; Bichraoui H; De Waard M; Hidalgo C; Bull R
Cell Calcium; 2013; 53(5-6):357-65. PubMed ID: 23623374
[TBL] [Abstract][Full Text] [Related]
6. Activation of skeletal ryanodine receptors by two novel scorpion toxins from Buthotus judaicus.
Zhu X; Zamudio FZ; Olbinski BA; Possani LD; Valdivia HH
J Biol Chem; 2004 Jun; 279(25):26588-96. PubMed ID: 15067003
[TBL] [Abstract][Full Text] [Related]
7. Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.
Tripathy A; Resch W; Xu L; Valdivia HH; Meissner G
J Gen Physiol; 1998 May; 111(5):679-90. PubMed ID: 9565405
[TBL] [Abstract][Full Text] [Related]
8. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
Altafaj X; Cheng W; Estève E; Urbani J; Grunwald D; Sabatier JM; Coronado R; De Waard M; Ronjat M
J Biol Chem; 2005 Feb; 280(6):4013-6. PubMed ID: 15591063
[TBL] [Abstract][Full Text] [Related]
9. Ryanoids and imperatoxin affect the modulation of cardiac ryanodine receptors by dihydropyridine receptor Peptide A.
Porta M; Diaz-Sylvester PL; Nani A; Ramos-Franco J; Copello JA
Biochim Biophys Acta; 2008 Nov; 1778(11):2469-79. PubMed ID: 18722342
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
11. Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor.
Boisseau S; Mabrouk K; Ram N; Garmy N; Collin V; Tadmouri A; Mikati M; Sabatier JM; Ronjat M; Fantini J; De Waard M
Biochim Biophys Acta; 2006 Mar; 1758(3):308-19. PubMed ID: 16545341
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional location of the imperatoxin A binding site on the ryanodine receptor.
Samsó M; Trujillo R; Gurrola GB; Valdivia HH; Wagenknecht T
J Cell Biol; 1999 Jul; 146(2):493-9. PubMed ID: 10427100
[TBL] [Abstract][Full Text] [Related]
13. A central core disease mutation in the Ca
Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
[TBL] [Abstract][Full Text] [Related]
14. Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms.
el-Hayek R; Lokuta AJ; Arévalo C; Valdivia HH
J Biol Chem; 1995 Dec; 270(48):28696-704. PubMed ID: 7499390
[TBL] [Abstract][Full Text] [Related]
15. Multiple actions of imperatoxin A on ryanodine receptors: interactions with the II-III loop "A" fragment.
Dulhunty AF; Curtis SM; Watson S; Cengia L; Casarotto MG
J Biol Chem; 2004 Mar; 279(12):11853-62. PubMed ID: 14699105
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1.
Fessenden JD; Feng W; Pessah IN; Allen PD
J Biol Chem; 2004 Dec; 279(51):53028-35. PubMed ID: 15469935
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A.
Lee CW; Lee EH; Takeuchi K; Takahashi H; Shimada I; Sato K; Shin SY; Kim DH; Kim JI
Biochem J; 2004 Jan; 377(Pt 2):385-94. PubMed ID: 14535845
[TBL] [Abstract][Full Text] [Related]
18. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor.
Mei Y; Xu L; Mowrey DD; Mendez Giraldez R; Wang Y; Pasek DA; Dokholyan NV; Meissner G
J Biol Chem; 2015 Jul; 290(28):17535-45. PubMed ID: 25998124
[TBL] [Abstract][Full Text] [Related]
19. Recombinant expression of Intrepicalcin from the scorpion Vaejovis intrepidus and its effect on skeletal ryanodine receptors.
Vargas-Jaimes L; Xiao L; Zhang J; Possani LD; Valdivia HH; Quintero-Hernández V
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):936-946. PubMed ID: 28159581
[TBL] [Abstract][Full Text] [Related]
20. Imperatoxin a enhances Ca(2+) release in developing skeletal muscle containing ryanodine receptor type 3.
Nabhani T; Zhu X; Simeoni I; Sorrentino V; Valdivia HH; García J
Biophys J; 2002 Mar; 82(3):1319-28. PubMed ID: 11867448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
